REPCF Stock Price, Chart, Stats & News

RepliCel Life Sciences Inc.
Save
RepliCel Life Sciences Inc. (REPCF) does not currently pay a dividend.
7,357
Market cap
–
Current P/E
–
Forward P/E
REPCF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
RepliCel Life Sciences Inc., a biotechnology firm based in Vancouver, Canada, specializes in regenerative medicine. The company focuses on developing patient-specific cell therapies designed to address functional cellular deficits. Their treatment methodology involves extracting an individual's own cells from harvested bodily tissues and then cultivating them further in a controlled laboratory environment.
Similar securities
Based on sector and market capitalization
Report issue





